254 related articles for article (PubMed ID: 31129084)
21. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
Gabriel E; Gopalakrishnan J
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
[TBL] [Abstract][Full Text] [Related]
22. Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.
Mansur F; Teles E Silva AL; Gomes AKS; Magdalon J; de Souza JS; Griesi-Oliveira K; Passos-Bueno MR; Sertié AL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299197
[TBL] [Abstract][Full Text] [Related]
23. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients.
Lim CS; Yang JE; Lee YK; Lee K; Lee JA; Kaang BK
Mol Brain; 2015 Sep; 8(1):57. PubMed ID: 26419846
[TBL] [Abstract][Full Text] [Related]
24. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments.
Zhang X; Li Z; Liu Y; Gai Z
Int J Med Sci; 2021; 18(2):459-473. PubMed ID: 33390815
[TBL] [Abstract][Full Text] [Related]
25. Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells.
Russo FB; Freitas BC; Pignatari GC; Fernandes IR; Sebat J; Muotri AR; Beltrão-Braga PCB
Biol Psychiatry; 2018 Apr; 83(7):569-578. PubMed ID: 29129319
[TBL] [Abstract][Full Text] [Related]
26. iPSC toolbox for understanding and repairing disrupted brain circuits in autism.
Chiola S; Edgar NU; Shcheglovitov A
Mol Psychiatry; 2022 Jan; 27(1):249-258. PubMed ID: 34497379
[TBL] [Abstract][Full Text] [Related]
27. Brain Organoids: Expanding Our Understanding of Human Development and Disease.
Chuye LB; Dimitri A; Desai A; Handelmann C; Bae Y; Johari P; Jornet JM; Klejbor I; Stachowiak MK; Stachowiak EK
Results Probl Cell Differ; 2018; 66():183-206. PubMed ID: 30209660
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
Sivanesan S; Tan A; Jeyaraj R; Lam J; Gole M; Hardan A; Ashkan K; Rajadas J
World Neurosurg; 2017 Feb; 98():659-672. PubMed ID: 27725300
[TBL] [Abstract][Full Text] [Related]
29. Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases.
Li L; Chao J; Shi Y
Cell Tissue Res; 2018 Jan; 371(1):143-151. PubMed ID: 29079884
[TBL] [Abstract][Full Text] [Related]
30. Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges.
Villa C; Combi R; Conconi D; Lavitrano M
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33669772
[TBL] [Abstract][Full Text] [Related]
31. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
van Hugte E; Nadif Kasri N
Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
[TBL] [Abstract][Full Text] [Related]
32. Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.
Griesi-Oliveira K; Acab A; Gupta AR; Sunaga DY; Chailangkarn T; Nicol X; Nunez Y; Walker MF; Murdoch JD; Sanders SJ; Fernandez TV; Ji W; Lifton RP; Vadasz E; Dietrich A; Pradhan D; Song H; Ming GL; Gu X; Haddad G; Marchetto MC; Spitzer N; Passos-Bueno MR; State MW; Muotri AR
Mol Psychiatry; 2015 Nov; 20(11):1350-65. PubMed ID: 25385366
[TBL] [Abstract][Full Text] [Related]
33. Modeling Inflammation on Neurodevelopmental Disorders Using Pluripotent Stem Cells.
Freitas BC; Beltrão-Braga PCB; Marchetto MC
Adv Neurobiol; 2020; 25():207-218. PubMed ID: 32578148
[TBL] [Abstract][Full Text] [Related]
34. Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities.
Young-Pearse TL; Morrow EM
Curr Opin Neurobiol; 2016 Feb; 36():66-73. PubMed ID: 26517284
[TBL] [Abstract][Full Text] [Related]
35. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
[TBL] [Abstract][Full Text] [Related]
36. Cerebral organoids as an in vitro model to study autism spectrum disorders.
Rabeling A; Goolam M
Gene Ther; 2023 Sep; 30(9):659-669. PubMed ID: 35790793
[TBL] [Abstract][Full Text] [Related]
37. Modeling autism spectrum disorders with human neurons.
Beltrão-Braga PC; Muotri AR
Brain Res; 2017 Feb; 1656():49-54. PubMed ID: 26854137
[TBL] [Abstract][Full Text] [Related]
38. The promises and challenges of human brain organoids as models of neuropsychiatric disease.
Quadrato G; Brown J; Arlotta P
Nat Med; 2016 Nov; 22(11):1220-1228. PubMed ID: 27783065
[TBL] [Abstract][Full Text] [Related]
39. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
Wang M; Zhang L; Gage FH
Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
[TBL] [Abstract][Full Text] [Related]
40. Probing disrupted neurodevelopment in autism using human stem cell-derived neurons and organoids: An outlook into future diagnostics and drug development.
Yang G; Shcheglovitov A
Dev Dyn; 2020 Jan; 249(1):6-33. PubMed ID: 31398277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
